Literature DB >> 1317505

Surveillance of congenital cytomegalovirus disease, 1990-1991. Collaborating Registry Group.

J G Dobbins1, J A Stewart, G J Demmler.   

Abstract

In January 1990, a registry was initiated for surveillance of infants with the often severe symptoms of congenital cytomegalovirus (CMV) disease. In the first 2 years, 100 cases were reported to the registry. Petechiae, the most commonly noted clinical sign, were reported for approximately 50% of infants, usually accompanied by hepatomegaly and splenomegaly. Of the various severe neurologic conditions that can result from congenital CMV infection, the most frequent was intracranial calcifications, which were noted in 43% of the cases. The most common laboratory abnormality was low platelet count, which was observed in 52% of the cases. Infants with severe neurologic damage were about twice as likely as infants with less severe damage to have most other clinical signs and laboratory abnormalities. Databases will be developed to facilitate comparisons among symptomatically infected infants and asymptomatically infected as well as noninfected infants.

Entities:  

Mesh:

Year:  1992        PMID: 1317505

Source DB:  PubMed          Journal:  MMWR CDC Surveill Summ


  11 in total

1.  National serosurvey of cytomegalovirus in Australia.

Authors:  Holly Seale; C Raina MacIntyre; Heather F Gidding; J L Backhouse; Dominic E Dwyer; Lyn Gilbert
Journal:  Clin Vaccine Immunol       Date:  2006-09-06

2.  Spliced mRNA encoding the murine cytomegalovirus chemokine homolog predicts a beta chemokine of novel structure.

Authors:  M R MacDonald; M W Burney; S B Resnick; I V Virgin HW
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

3.  Magnetic resonance imaging of cerebellar cysts in a neonate with congenital cytomegalovirus infection.

Authors:  Miguel Quintas-Neves; João Paulo Soares-Fernandes
Journal:  Pediatr Radiol       Date:  2019-01-05

4.  Seroprevalence of cytomegalovirus (CMV) and risk factors for infection in adolescent males.

Authors:  Laura Patricia Stadler; David I Bernstein; S Todd Callahan; Jennifer Ferreira; Gina A Gorgone Simone; Kathryn M Edwards; Lawrence R Stanberry; Susan L Rosenthal
Journal:  Clin Infect Dis       Date:  2010-10-11       Impact factor: 9.079

5.  Mucosal and parenteral vaccination against acute and latent murine cytomegalovirus (MCMV) infection by using an attenuated MCMV mutant.

Authors:  M R MacDonald; X Y Li; R M Stenberg; A E Campbell; H W Virgin
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

6.  A comparative study of congenital and postnatally acquired human cytomegalovirus infection in infants: lack of expression of viral immediate early protein in congenital cases.

Authors:  A Maeda; T Sata; Y Sato; T Kurata
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

7.  Pp65 antigenemia, plasma real-time PCR and DBS test in symptomatic and asymptomatic cytomegalovirus congenitally infected newborns.

Authors:  Sandro Binda; Antonella Mammoliti; Valeria Primache; Patrizia Didò; Carlo Corbetta; Fabio Mosca; Lorenza Pugni; Anna Bossi; Cristian Ricci; Maria Barbi
Journal:  BMC Infect Dis       Date:  2010-02-11       Impact factor: 3.090

8.  Washing our hands of the congenital cytomegalovirus disease epidemic.

Authors:  Michael J Cannon; Katherine Finn Davis
Journal:  BMC Public Health       Date:  2005-06-20       Impact factor: 3.295

9.  Seroprevalence and Risk Factors for Cytomegalovirus Infections in Adolescent Females.

Authors:  Laura Patricia Stadler; David I Bernstein; S Todd Callahan; Christine B Turley; Flor M Munoz; Jennifer Ferreira; Mekhala Acharya; Gina A Gorgone Simone; Shital M Patel; Kathryn M Edwards; Susan L Rosenthal
Journal:  J Pediatric Infect Dis Soc       Date:  2012-08-03       Impact factor: 3.164

10.  Knowledge and awareness of congenital cytomegalovirus among women.

Authors:  Jiyeon Jeon; Marcia Victor; Stuart P Adler; Abigail Arwady; Gail Demmler; Karen Fowler; Johanna Goldfarb; Harry Keyserling; Mehran Massoudi; Kristin Richards; Stephanie A S Staras; Michael J Cannon
Journal:  Infect Dis Obstet Gynecol       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.